Latest Insider Transactions at Aerovate Therapeutics, Inc. (AVTE)
This section provides a real-time view of insider transactions for Aerovate Therapeutics, Inc. (AVTE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aerovate Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aerovate Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 06
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
13,040
-78.05%
|
$208,640
$16.5 P/Share
|
Oct 06
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
13,040
+47.45%
|
$13,040
$1.94 P/Share
|
Oct 05
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-31.98%
|
$33,750
$15.97 P/Share
|
Oct 05
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
Sep 12
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
7,520
-86.0%
|
$127,840
$17.98 P/Share
|
Sep 12
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
7,520
+50.0%
|
$15,040
$2.14 P/Share
|
Sep 09
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
4,720
-98.14%
|
$84,960
$18.02 P/Share
|
Sep 09
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
4,720
+49.3%
|
$4,720
$1.94 P/Share
|
Sep 08
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,120
-89.92%
|
$56,160
$18.28 P/Share
|
Sep 08
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,120
+50.0%
|
$3,120
$1.74 P/Share
|
Sep 07
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,662
-50.05%
|
$65,916
$18.27 P/Share
|
Sep 07
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
8,220
+50.0%
|
$8,220
$1.74 P/Share
|
Sep 06
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
9,166
-78.49%
|
$164,988
$18.9 P/Share
|
Sep 06
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
9,166
+50.0%
|
$9,166
$1.74 P/Share
|
Sep 06
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$42,750
$19.0 P/Share
|
Sep 06
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
Aug 18
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$47,250
$21.18 P/Share
|
Aug 18
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
Aug 16
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
21,000
-72.36%
|
$483,000
$23.28 P/Share
|
Aug 16
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+50.0%
|
$21,000
$1.74 P/Share
|
Aug 11
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
1,347
-97.07%
|
$32,328
$24.22 P/Share
|
Aug 11
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
1,347
+50.0%
|
$1,347
$1.74 P/Share
|
Aug 10
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
12,720
-96.93%
|
$305,280
$24.27 P/Share
|
Aug 10
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
12,720
+50.0%
|
$12,720
$1.74 P/Share
|
Aug 09
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
8,700
-83.96%
|
$208,800
$24.18 P/Share
|
Aug 09
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+50.0%
|
$8,700
$1.74 P/Share
|
Aug 08
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
6,943
-78.73%
|
$166,632
$24.67 P/Share
|
Aug 08
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
6,943
+50.0%
|
$6,943
$1.74 P/Share
|
Jul 15
2022
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
310,388
-11.76%
|
-
|
Apr 01
2022
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
465,582
-15.0%
|
-
|
Jul 02
2021
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
500,000
+19.76%
|
$7,000,000
$14.0 P/Share
|
Jul 02
2021
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,530,691
+50.0%
|
-
|
Jul 02
2021
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
535,714
+14.72%
|
$7,499,996
$14.0 P/Share
|
Jul 02
2021
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,568,165
+50.0%
|
-
|
Jul 02
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
357,142
+8.68%
|
$4,999,988
$14.0 P/Share
|
Jul 02
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,401,544
+50.0%
|
-
|
Jul 02
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
5,236,801
+49.5%
|
-
|
Jul 02
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,785,714
+28.57%
|
$38,999,996
$14.0 P/Share
|
Jul 02
2021
|
David S. Grayzel |
BUY
Open market or private purchase
|
Indirect |
535,714
+14.72%
|
$7,499,996
$14.0 P/Share
|
Jul 02
2021
|
David S. Grayzel |
BUY
Conversion of derivative security
|
Indirect |
2,568,165
+50.0%
|
-
|
Jul 02
2021
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
357,142
+8.68%
|
$4,999,988
$14.0 P/Share
|
Jul 02
2021
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
3,401,544
+50.0%
|
-
|